The next 10Q is the Acid Test with 20 + Dispensares and Overhead Cost Reductions. they still have operational expenses so I doubt very much their Cost Reductions will allow them to Break even. Unfortunately More Dilution on the immediate horizon, could see trips with the next round of Dilution.